Oligopeptide-34 in Thailand: Skin Brightening & Anti-Pigmentation Therapy
Oligopeptide-34 is a targeted skin peptide that downregulates tyrosinase expression to inhibit melanin synthesis and reduce hyperpigmentation, supporting even skin tone and complexion clarity. It is used in physician-supervised topical protocols for melasma, sun damage, and post-inflammatory pigment correction.
Doctor-prescribed Oligopeptide-34 in Thailand is available at Peptides Thailand under physician supervision, with clinical-grade, COA-verified topical formulation. It is prescribed for skin tone correction and hyperpigmentation protocols, particularly for patients seeking a clinically grounded approach to uneven complexion and melanin regulation.
How Oligopeptide-34 Works
Oligopeptide-34 operates through sophisticated pathways to regulate melanin production and distribution. Its primary mechanism involves modulating tyrosinase activity and melanocyte function, leading to more balanced pigment production. The peptide also demonstrates significant effects on melanin transfer to keratinocytes and helps regulate the overall pigmentation process. Additionally, it supports skin barrier function and demonstrates protective properties against environmental factors that can trigger hyperpigmentation.
Medical Review Status
Last reviewed: June 2026 | Next review: December 2026
Written by Dr. Michael Ackland · Medically reviewed by Dr. Ploy Pitayanon, MD, licensed by the Medical Council of Thailand
At a Glance
Peptide
Oligopeptide-34
Category
Topical Peptide
Dosage
1 ml (4 clicks) per application
Frequency
Once daily (evening)
Administration
Topical application
Potential Benefits
- · Reduces hyperpigmentation
- · Evens skin tone
- · Brightens complexion
Quality Matters
Why we use Clinical-Grade only
Certificate of Analysis
Every peptide we dispense comes with a third-party COA confirming purity and potency, never grey-market sourced.
Compounded in Thailand
Manufactured in Thai FDA-licensed compounding laboratories operating under GMP standards.
Physician-prescribed only
No dispensing without a prescription. Every protocol begins with a licensed physician consultation and clinical assessment.
Medical Disclaimer
The information on this page is intended for educational and informational purposes only and should not be considered medical advice, diagnosis, or treatment. Any therapies, consultations, or prescriptions are provided only following assessment by a licensed physician and where clinically appropriate. Individual results may vary and no specific outcomes are guaranteed. Certain compounds discussed may not be approved medicines registered with the Thai FDA for specific therapeutic indications. Nothing here should be interpreted as a recommendation to self diagnose, self treat, or replace consultation with a qualified healthcare professional.
Doctor's Note
Dr. Ploy Pitayanon, MD, Medical Lead
Oligopeptide-34 requires careful medical supervision and individualized dosing. Our clinics in Chiang Mai and Phuket provide comprehensive assessment, monitoring, and ongoing support to ensure safe and effective treatment outcomes.
Potential Benefits
Reduces hyperpigmentation
Evens skin tone
Brightens complexion
Regulates melanin production
Improves skin clarity
Supports skin barrier function
Enhances skin radiance
Reduces dark spots
Promotes uniform pigmentation
Supports overall skin health
Speak with a physician
Interested in Oligopeptide-34?
All protocols require a physician assessment before any prescription is issued. Book a free video consultation with an MCT-licensed doctor.
Treatment Protocol
Dosage
1 ml (4 clicks) per application
Frequency
Once daily (evening)
Duration
12-16 weeks for optimal results
Administration
Topical application
Safety guide
Oligopeptide-34 Side Effects & Safety
Frequency, contraindications, and who is a good candidate
Recent Oligopeptide-34 Research
Peptide Design for Enhanced Anti-Melanogenesis: Optimizing Molecular Weight, Polarity, and Charge
Demonstrated that optimising peptide physicochemical properties improves skin penetration and tyrosinase inhibitory activity for anti-melanogenesis, supporting the rational design of peptides like oligopeptide-34 for hyperpigmentation control (Drug Des Devel Ther, 2025).
View on PubMedMelanocyte Activation Mechanisms and Rational Therapeutic Treatments of Solar Lentigos
Characterised the molecular pathways driving melanocyte activation and excess melanin production in solar lentigos, providing mechanistic context for peptide-based interventions targeting the melanogenesis cascade (Int J Mol Sci, 2019).
View on PubMedAnti-melanogenesis Effect via Downregulation of MITF and the PKA/CREB Signalling Pathway
Demonstrated that inhibition of the MITF transcription factor via PKA/CREB pathway suppresses melanin synthesis, describing the signalling cascade relevant to topical anti-pigmentation peptide actives (Pharmacol Rep, 2018).
View on PubMedRelated Peptides
Prefer to message first?
Chat with our team on WhatsApp. We typically reply within minutes.
Chat about Oligopeptide-34